1202769-66-1 Usage
Description
2-(5-Methylisoxazol-3-yl)but-3-yn-2-ol is a chemical compound characterized by the molecular formula C9H9NO2. It is an isoxazole derivative featuring a five-membered heterocyclic ring with a methyl group at the third position. The molecule is distinguished by the presence of a butyn-3-ynyl group and an alcohol functional group, which contribute to its unique chemical properties and potential applications in various fields.
Uses
Used in Organic Synthesis:
2-(5-Methylisoxazol-3-yl)but-3-yn-2-ol is utilized as a building block in organic synthesis for the creation of more complex molecules. Its unique structure and functional groups make it a valuable component in the synthesis of various organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(5-Methylisoxazol-3-yl)but-3-yn-2-ol is employed as a starting material or intermediate in the development of new drugs. Its potential pharmacological activities and biological effects have attracted interest for its use in medicinal chemistry, where it can be modified or combined with other compounds to create novel therapeutic agents.
Used in Chemical Research:
2-(5-Methylisoxazol-3-yl)but-3-yn-2-ol is also used in chemical research to study its properties and reactivity. Understanding its behavior in various chemical reactions can provide insights into the development of new synthetic methods and the discovery of new compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1202769-66-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,7,6 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1202769-66:
(9*1)+(8*2)+(7*0)+(6*2)+(5*7)+(4*6)+(3*9)+(2*6)+(1*6)=141
141 % 10 = 1
So 1202769-66-1 is a valid CAS Registry Number.
1202769-66-1Relevant articles and documents
SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE
-
Page/Page column 158; 159, (2020/12/11)
The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.
6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR
-
, (2015/05/06)
The invention relates to novel compounds of Formula I: wherein A, Y, R1, R2 and the subscript b each has the meaning as described herein and compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates, metabolites, isotopes, pharmaceutically acceptable salts, or prodrugs thereof. Compounds of Formula I and pharmaceutical compositions thereof are useful in the treatment of disease and disorders in which undesired or over-activation of NF-kB signaling is observed.
